Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Takeda Opens China Clinical Trial Center in Shanghai

publication date: Aug 9, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Takeda Pharma, the largest pharma in Japan, has officially opened its new headquarters for clinical trials in China, called the Takeda Shanghai Development Center. The new facility will be responsible for Takeda’s general medicine clinical trials in China and oncology treatments across Asia. The company said the new facility underscores its commitment to Asia and China in particular. More details....

Stock Symbol: (TSE: 4502)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...